Huitai Medical plans to acquire 37.33%equity of Shanghai Hongtong

Titanium Media APP June 14th news, Shenzhen Huitai Medical Device Co., Ltd. announced that the company plans to use 586 million yuan in two steps to acquire the holding subsidiary Shanghai Hongtong minority shareholder Zhang Xiangmei and other 9 people. Tong 37.33%equity. The company and the above -mentioned minority shareholders were determined that the transaction was determined by the valuation of 100%equity of Shanghai Hongtong 1.569 billion yuan. After the acquisition is completed, the company will hold 100%equity of Shanghai Hongtong. On the same day, it was announced that it was not less than 50 million yuan, and no more than 100 million yuan of companies shares; the repurchase price did not exceed 270 yuan/share.

Company information shows that Huitai Medical was established in June 2002 and was listed on the Shanghai Stock Exchange Science and Technology Board in January 2021. It is a high -tech of the research and development, production and sales of heart electrical and interventional medical devices. enterprise. The company has now formed a business layout that focuses on the entire coronary pathway and cardiac electrical physiological medical devices, and peripheral blood vessels and neuro intervention medical devices as the focus of development direction. As of December 31, 2021, in the domestic market, the company's cardiac electrical products covered more than 800 hospitals, and more than 2,000 blood vessel interventional products covered more than 2,000 hospitals. At the same time, the company has obtained 14 EU CE certifications and has completed registration and market access in more than 90 countries and regions.

In the field of electro -physiological equipment, Huitai Medical is the first manufacturer to obtain electrical electrode catheter, controllable radio frequency ablation electrode catheter, floating temporary pairing electrode catheter market access and entering clinical applications, breaking the foreign products Domain monopoly. The company's three -dimensional cardiac electrical bidding system adopts the principle of international mainstream magnetic and electrical integration positioning, and innovatively combines the function of the three -dimensional labeling system, multi -channel recorder, and stimulator function commonly used in electro -physiological surgery, which greatly improves surgical efficiency , Push the development of the cardiac electrical bidding system to a new height.

According to smart bud data, Huitai Medical and its related companies currently have more than 220 patent applications, of which more than 130 invention patents are invention. The company's patent layout is mainly focused on related fields such as RFC and electrode catheter.

- END -